
Otonomy OTIC
Quarterly report 2022-Q3
added 11-10-2022
Otonomy Total Inventories 2011-2026 | OTIC
Annual Total Inventories Otonomy
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 227 K | - | - | 6 K | 1.44 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.44 M | 6 K | 556 K |
Quarterly Total Inventories Otonomy
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 455 K | 227 K | - | - | - | 478 K | - | - | - | - | - | - | - | 6 K | 1.24 M | 1.19 M | 1.2 M | 1.44 M | 1.44 M | 1.44 M | 1.44 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.44 M | 6 K | 958 K |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amarin Corporation plc
AMRN
|
196 M | $ 14.67 | -0.07 % | $ 6.09 B | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Arena Pharmaceuticals
ARNA
|
6.71 M | - | -6.81 % | $ 3.04 B | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M | ||
|
Avid Bioservices
CDMO
|
30.4 M | - | - | $ 789 M | ||
|
Autolus Therapeutics plc
AUTL
|
4.14 M | $ 1.29 | -3.01 % | $ 329 M | ||
|
CEL-SCI Corporation
CVM
|
1.02 M | $ 3.47 | -1.7 % | $ 221 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
2.82 M | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
851 K | - | - | $ 3.74 B | ||
|
Esperion Therapeutics
ESPR
|
105 M | $ 2.85 | 3.26 % | $ 592 M | ||
|
Eton Pharmaceuticals
ETON
|
15.4 M | $ 23.45 | -1.64 % | $ 631 M | ||
|
China SXT Pharmaceuticals
SXTC
|
828 K | $ 1.32 | -5.2 % | $ 1.88 M |